Bicycle Therapeutics (BCYC) Tax Provisions (2018 - 2026)
Bicycle Therapeutics (BCYC) reported Tax Provisions of $172000.0 for Q1 2026, up 115.64% on a YoY basis from $79763.9 in Q1 2025, and down 86.9% quarter-over-quarter from $1.3 million in Q4 2025.
Bicycle Therapeutics (BCYC) Tax Provisions (2018 - 2026) Analysis & Trends
Bicycle Therapeutics has reported Tax Provisions for 9 years, with the latest figure at $172000.0 in Q1 2026.
- For the quarter ending Q1 2026, Tax Provisions rose 115.64% year-over-year to $172000.0; the trailing twelve-month figure through Mar 2026 stood at $1.5 million (up 126.45% YoY), and the FY2025 full-year result was $200000.0, up 104.17% from the prior year.
- Tax Provisions for Q1 2026 stood at $172000.0, down from $1.3 million in the prior quarter.
- The five-year high for Tax Provisions was $2.3 million in Q3 2023, with the low at -$3.4 million in Q3 2024.
- Historically, Tax Provisions has averaged -$255352.9 across 5 years, with a median of -$400000.0 in 2022.
- Annual changes were most pronounced in 2023 — Tax Provisions soared 1236.0% — and 2024, when it sank 407.71%.
- Bicycle Therapeutics' Tax Provisions stood at -$400000.0 in 2022, then surged by 190.75% to $363000.0 in 2023, then slumped by 407.71% to -$1.1 million in 2024, then soared by 217.55% to $1.3 million in 2025, then slumped by 86.9% to $172000.0 in 2026.
- The last three Tax Provisions figures came in at $172000.0 (Q1 2026), $1.3 million (Q4 2025), and $205000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -11.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 216,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -859,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 221.50 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Bicycle Therapeutics | 278.04 Mn | 278.04 Mn | - | 172,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 172,000.00 |
| Dec 31, 2025 | 1.31 Mn |
| Sep 30, 2025 | 205,000.00 |
| Jun 30, 2025 | -231,000.00 |
| Mar 31, 2025 | -1.10 Mn |
| Dec 31, 2024 | -1.12 Mn |
| Sep 30, 2024 | -3.40 Mn |
| Jun 30, 2024 | 100,000.00 |
| Mar 31, 2024 | -400,000.00 |
| Dec 31, 2023 | 363,000.00 |
| Sep 30, 2023 | 2.27 Mn |
| Jun 30, 2023 | -500,000.00 |
| Mar 31, 2023 | -618,000.00 |
| Dec 31, 2022 | -400,000.00 |
| Sep 30, 2022 | -200,000.00 |
| Jun 30, 2022 | -400,000.00 |
| Mar 31, 2022 | -400,000.00 |
| Dec 31, 2021 | 920,000.00 |
| Sep 30, 2021 | -400,000.00 |
| Jun 30, 2021 | -200,000.00 |